Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Martin

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Annals of Neurology|November 15, 2001
Human herpesvirus 6 limbic encephalitis after stem cell transplantationM S Wainwright, P L Martin, R P Morse, et al.
Leukemia|June 19, 2014
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaP Satwani, Z Jin, P L Martin, et al.
Bone Marrow Transplantation|June 5, 1998
Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemiaM L Graham, B L Asselin, J E Herndon, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Annals of Neurology|November 15, 2001
Human herpesvirus 6 limbic encephalitis after stem cell transplantationM S Wainwright, P L Martin, R P Morse, et al.
Leukemia|June 19, 2014
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaP Satwani, Z Jin, P L Martin, et al.
Bone Marrow Transplantation|June 5, 1998
Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemiaM L Graham, B L Asselin, J E Herndon, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 11